Open Access
CC BY-NC-ND 4.0 · J Neurol Surg B Skull Base 2019; 80(01): 082-087
DOI: 10.1055/s-0038-1667061
Original Article
Georg Thieme Verlag KG Stuttgart · New York

The Feasibility of a Modified Exclusive Endoscopic Transcanal Transpromontorial Approach for Vestibular Schwannomas

In Seok Moon
1   Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea
,
Dongchul Cha
1   Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea
,
Sung-Il Nam
2   Department of Otorhinolaryngology, Keimyung University College of Medicine, Daegu, Korea
,
Hyun-Jin Lee
3   Department of Otorhinolaryngology, Gyeongsang National University Changwon Hospital, Changwon, Korea
,
Jae Young Choi
1   Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea
› Author Affiliations

Funding This study was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2058141).
Further Information

Publication History

27 January 2018

06 June 2018

Publication Date:
30 July 2018 (online)

Preview

Abstract

Objective We evaluated the feasibility of an exclusive endoscopic transcanal transpromontorial approach (EETTA) for the treatment of small vestibular schwannomas (VSs) limited to the internal auditory canal (IAC), and introduced a modification without external auditory canal closure.

Methods Between June 2016 and June 2017, seven patients with VS underwent surgery using a modified EETTA. Treatment outcomes, including efficacy of tumor resection, preservation of function, operation time, and quality of life (QOL), were evaluated.

Results The patients preoperatively exhibited Koos Grade I/II tumors and severe-to-profound hearing loss. Gross total resection was accomplished in all cases. There were no major complications, and all patients exhibited normal facial nerve function immediately after surgery. The mean follow-up period was 12.9 months. The operation time (average 196.3 ± 64.9 minutes) and hospitalization period (average 7.4 ± 1.0 days) were favorable. Short Form-36 scores for QOL showed unremarkable results compared with previous reports.

Conclusions The modified EETTA was effective in the removal of VSs in the IAC. It can be an alternative surgical option for small VSs.

Supplementary Material